Centuple Global Limited (BOM:531099)
36.30
+1.65 (4.76%)
At close: Aug 24, 2026
Centuple Global Revenue
Centuple Global had revenue of 5.62B INR in the twelve months ending June 30, 2026, up 4,540.11% year-over-year. In the fiscal year ending March 31, 2026, Centuple Global had annual revenue of 5.74B with 114,387.41% growth.
Revenue (ttm)
5.62B
Revenue Growth
+4,540.11%
P/S Ratio
0.04
Revenue / Employee
1.41B
Employees
4
Market Cap
202.33M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.74B | 5.73B | 114,387.41% |
| Mar 31, 2025 | 5.01M | -6.30M | -55.68% |
| Mar 31, 2024 | 11.31M | -308.79K | -2.66% |
| Mar 31, 2023 | 11.62M | -8.50M | -42.26% |
| Mar 31, 2022 | 20.12M | 15.27M | 314.82% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dipna Pharmachem | 1.29B |
| Chandra Bhagat Pharma | 1.17B |
| Medico Intercontinental | 845.82M |
| Medistep Healthcare | 708.31M |
| Zenlabs Ethica | 496.22M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |
| Muller & Phipps (India) | 67.05M |